InnoCare Pharma

Biogen CEO says company 'lost its way,' cuts $125M MS partnership amid declining revenue
Endpoints
Wed, 02/15/23 - 06:30 pm
Biogen
InnoCare Pharma
orelabrutinib
earnings
Pandemic fears force Chinese biotech to postpone Hong Kong IPO meetings — Bloomberg
Endpoints
Mon, 02/3/20 - 10:30 am
China
Hong Kong
IPOs
Wuhan Coronavirus
InnoCare Pharma